immunogenicity and efficacy of live l. tarentolae expressing kmp11-ntgp96-gfp fusion as a vaccine candidate against experimental visceral leishmaniasis caused by l. infantum
نویسندگان
چکیده
background: the aim of present study was to evaluate the protective efficacy of live recombinant l. tarentolae expressing kmp11-ntgp96-gfp fusion as candidates for live engineered recombinant vaccine against visceral leishmaniasis in balb/c mice. methods: kmp-11 and nt-gp96 genes cloned into the pjet1.2/blunt cloning vector and then into pegfp-n1 expression vector. the kmp-11, nt-gp96 and gfp fused in pegfp-n1 and subcloned into leishmania n plexsy-neo vector. finally this construct was transferred to l. tarentolae by electroporation. tranfection was confirmed by sds-page, western blot, flowcytometry and rt-pcr. protective efficacy of this construct was evaluated as a vaccine candidate against visceral leishmaniasis. parasite burden, humoral and cellular immune responses were assessed before and at 4 weeks after challenge. results: kmp- nt-gp96-gfp fusion was cloned successfully into plexsy -neo vector and this construct successfully transferred to l. tarentolae . finding indicated that immunization with l. tarentolae tarentolae -kmp11-ntgp96-gfp provides significant protection against visceral leishmaniasis and was able to induce an increased expression of ifn-γ and igg2a. following challenge, a reduced parasite load in the spleen of the kmp11-ntgp96-gfp immunized group was detected. conclusion: the present study is the first to use a combination of a leishmania antigen with an immunologic antigen in live recombinant l. tarentolae and results suggest that l. tarentolae -kmp11-ntgp96-gfp could be considered as a potential tool in vaccination against visceral leishmaniasis and this vaccination strategy could provide a potent rout for future vaccine development.
منابع مشابه
Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum
BACKGROUND The aim of present study was to evaluate the protective efficacy of live recombinant L. tarentolae expressing KMP11-NTGP96-GFP fusion as candidates for live engineered recombinant vaccine against visceral leishmaniasis in BALB/c mice. METHODS KMP-11 and NT-GP96 genes cloned into the pJET1.2/blunt cloning vector and then into pEGFP-N1 expression vector. The KMP-11, NT-GP96 and GFP f...
متن کاملEvaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
Canine Visceral Leishmaniasis (CVL) is a major veterinary and public health problem caused by Leishmania infantum (L. infantum) in many endemic countries. It is a severe chronic disease with generalized parasite spread to the reticuloendothelial system, such as spleen, liver and bone marrow and is often fatal when left untreated. Control of VL in dogs would dramatically decrease infection press...
متن کاملAntileishmanial efficacy of Boerhaavia diffusa L. and Ocimum sanctum L. against experimental visceral leishmaniasis.
The chemotherapy of visceral leishmaniasis (VL) has several limitations including resistance and toxicity of the existing drugs. Down regulation of immune system further aggravates the problems. To combat this situation we evaluated the leishmanicidal efficacy of Boerhaavia diffusa and Ocimum sanctum through oral route in L. donovani infection in BALB/c mice. Results have demonstrated maximum c...
متن کاملLive nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.
To date, there are no proven vaccines against any form of leishmaniasis. The development of live attenuated vectors shows promise in the field of Leishmania vaccination because these organisms mimic more effectively the course of real infections and can elicit potent activation of the immune system. In the present study, we investigated the potential of a parasitic protozoan that is nonpathogen...
متن کاملDevelopment of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
Visceral leishmaniasis (VL) is a vector-borne disease affecting humans and domestic animals that constitutes a serious public health problem in many countries. Although many antigens have been examined so far as protein- or DNA-based vaccines, none of them conferred complete long-term protection. The use of the lizard non-pathogenic to humans Leishmania (L.) tarentolae species as a live vaccine...
متن کاملEnhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
BACKGROUND Novel vaccination approaches are needed to prevent leishmaniasis. Live attenuated vaccines are the gold standard for protection against intracellular pathogens such as Leishmania and there have been new developments in this field. The nonpathogenic to humans lizard protozoan parasite, Leishmania (L) tarentolae, has been used effectively as a vaccine platform against visceral leishman...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of parasitologyجلد ۱۱، شماره ۲، صفحات ۱۴۴-۱۵۸
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023